Annual EBIT
-$123.08 M
-$27.00 M-28.10%
December 31, 2022
Summary
- As of February 10, 2025, TCRR annual earnings before interest & taxes is -$123.08 million, with the most recent change of -$27.00 million (-28.10%) on December 31, 2022.
- During the last 3 years, TCRR annual EBIT has fallen by -$71.70 million (-139.54%).
Performance
TCRR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$37.47 M
-$6.46 M-20.84%
March 31, 2023
Summary
- As of February 10, 2025, TCRR quarterly earnings before interest & taxes is -$37.47 million, with the most recent change of -$6.46 million (-20.84%) on March 31, 2023.
- Over the past year, TCRR quarterly EBIT has dropped by -$8.83 million (-30.82%).
Performance
TCRR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$131.34 M
-$8.83 M-7.20%
March 31, 2023
Summary
- As of February 10, 2025, TCRR TTM earnings before interest & taxes is -$131.34 million, with the most recent change of -$8.83 million (-7.20%) on March 31, 2023.
- Over the past year, TCRR TTM EBIT has dropped by -$28.22 million (-27.36%).
Performance
TCRR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TCRR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.1% | -30.8% | -27.4% |
| 3 y3 years | -139.5% | -130.9% | -131.1% |
| 5 y5 years | -833.9% | -810.9% | -155.6% |
TCRR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +28.1% | at low | +56.4% | at low | +36.7% | at low |
| 5 y | 5-year | +139.5% | at low | +176.1% | at low | +155.6% | at low |
| alltime | all time | +1139.5% | at low | +828.1% | at low | +3153.5% | at low |
TCR2 Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$37.47 M(+20.8%) | -$131.34 M(+7.2%) |
| Dec 2022 | -$123.08 M(+28.1%) | -$31.00 M(-0.3%) | -$122.52 M(+6.1%) |
| Sep 2022 | - | -$31.10 M(-2.1%) | -$115.47 M(+4.4%) |
| Jun 2022 | - | -$31.77 M(+10.9%) | -$110.61 M(+7.3%) |
| Mar 2022 | - | -$28.64 M(+19.6%) | -$103.13 M(+7.3%) |
| Dec 2021 | -$96.08 M(+39.9%) | -$23.96 M(-8.7%) | -$96.08 M(+5.9%) |
| Sep 2021 | - | -$26.24 M(+8.0%) | -$90.69 M(+11.1%) |
| Jun 2021 | - | -$24.29 M(+12.5%) | -$81.64 M(+10.2%) |
| Mar 2021 | - | -$21.59 M(+16.3%) | -$74.07 M(+7.8%) |
| Dec 2020 | -$68.70 M | -$18.57 M(+8.0%) | -$68.70 M(+7.8%) |
| Sep 2020 | - | -$17.19 M(+2.8%) | -$63.70 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$16.72 M(+3.0%) | -$61.41 M(+8.1%) |
| Mar 2020 | - | -$16.23 M(+19.6%) | -$56.83 M(+10.6%) |
| Dec 2019 | -$51.38 M(+94.2%) | -$13.57 M(-8.9%) | -$51.38 M(+11.1%) |
| Sep 2019 | - | -$14.90 M(+22.7%) | -$46.25 M(+20.3%) |
| Jun 2019 | - | -$12.14 M(+12.7%) | -$38.45 M(+16.1%) |
| Mar 2019 | - | -$10.78 M(+27.7%) | -$33.12 M(+25.2%) |
| Dec 2018 | -$26.45 M(+100.7%) | -$8.44 M(+19.1%) | -$26.45 M(+20.0%) |
| Sep 2018 | - | -$7.09 M(+4.1%) | -$22.05 M(+47.4%) |
| Jun 2018 | - | -$6.81 M(+65.5%) | -$14.96 M(+83.5%) |
| Mar 2018 | - | -$4.11 M(+1.9%) | -$8.15 M(+101.9%) |
| Dec 2017 | -$13.18 M(+32.7%) | -$4.04 M | -$4.04 M |
| Dec 2016 | -$9.93 M | - | - |
FAQ
- What is TCR2 Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual EBIT year-on-year change?
- What is TCR2 Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly EBIT year-on-year change?
- What is TCR2 Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for TCR2 Therapeutics?
- What is TCR2 Therapeutics TTM EBIT year-on-year change?
What is TCR2 Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TCRR is -$123.08 M
What is the all time high annual EBIT for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual earnings before interest & taxes is -$9.93 M
What is TCR2 Therapeutics annual EBIT year-on-year change?
Over the past year, TCRR annual earnings before interest & taxes has changed by -$27.00 M (-28.10%)
What is TCR2 Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TCRR is -$37.47 M
What is the all time high quarterly EBIT for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly earnings before interest & taxes is -$4.04 M
What is TCR2 Therapeutics quarterly EBIT year-on-year change?
Over the past year, TCRR quarterly earnings before interest & taxes has changed by -$8.83 M (-30.82%)
What is TCR2 Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TCRR is -$131.34 M
What is the all time high TTM EBIT for TCR2 Therapeutics?
TCR2 Therapeutics all-time high TTM earnings before interest & taxes is -$4.04 M
What is TCR2 Therapeutics TTM EBIT year-on-year change?
Over the past year, TCRR TTM earnings before interest & taxes has changed by -$28.22 M (-27.36%)